Retraction
MicroRNA‑203 inhibits malignant melanoma cell migration by targeting versican
Paper Information
Record ID:
50576
Author(s):
Journal:
Publication Date:
May 12, 2014
Retraction Date:
November 20, 2023
(2.0 years years ago)
Subjects:
Institution:
Department of Burns, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3892/etm.2023.12308Additional Notes:
see also: https://pubpeer.com/publications/E90686ECA59A1A587DF89128D30C75
Citations (28)
28
Total Citations0
Post-Retraction28
Pre-Retraction0
Same DayMicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets
Soudeh Ghafouri‐Fard, Mahdi Gholipour, Mohammad Taheri
Frontiers in Oncology
Open Access
Published: Apr 2021
43 citations
43 citations
942 days before retraction
A multi-omics study on cutaneous and uveal melanoma
Qi Zhang, Zenan Lin, Jie Chen et al. (4 authors)
International Journal of Ophthalmology
Open Access
Published: Jan 2021
3 citations
3 citations
1051 days before retraction
Distinguishing Tumor and Stromal Sources of MicroRNAs Linked to Metastasis in Cutaneous Melanoma
Kathleen Watt, Kathrin Tyryshkin, Neil Renwick et al. (4 authors)
Translational Oncology
Open Access
Published: May 2020
7 citations
7 citations
1271 days before retraction
Epigenetic inactivation of miR-203 as a key step in the neural crest epithelial-to-mesenchymal transition
Estefania sanchez vasquez
Unknown Journal
Open Access
Published: May 2020
1 citation
1 citation
1278 days before retraction
A novel chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products
Keke Li, Shuang Zhao, Jing Long et al. (10 authors)
Cancer Cell International
Open Access
Published: Jan 2020
27 citations
27 citations
1390 days before retraction
Importance of microRNAs in Skin Oncogenesis and Their Suitability as Agents and Targets for Topical Therapy
Dennis Gerloff, Cord Sunderkötter, Johannes Wohlrab
Skin Pharmacology and Physiology
Open Access
Published: Jan 2020
18 citations
18 citations
1419 days before retraction
Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signalling
Nidhi Gupta, Raman Kumar, Tulika Seth et al. (5 authors)
RNA Biology
Open Access
Published: Sep 2019
18 citations
18 citations
1524 days before retraction
MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas
Virginia Valentini, Veronica Zelli, Emanuela Gaggiano et al. (13 authors)
Anticancer Research
Open Access
Published: Jul 2019
13 citations
13 citations
1573 days before retraction
MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma
Natalia García‐Sancha, Roberto Corchado‐Cobos, Jesús Pérez‐Losada et al. (4 authors)
International Journal of Molecular Sciences
Open Access
Published: May 2019
84 citations
84 citations
1663 days before retraction
Epigenetic inactivation of miR-203 as a key step in neural crest epithelial-to-mesenchymal transition
Estefanía Sánchez-Vásquez, Marianne Bronner‐Fraser, Pablo H. Strobl‐Mazzulla
Development
Open Access
Published: Mar 2019
25 citations
25 citations
1701 days before retraction
Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma
Nidhi Gupta, Raman Kumar, Tulika Seth et al. (6 authors)
Journal of Cancer Research and Clinical Oncology
Published: Mar 2019
37 citations
37 citations
1707 days before retraction
Epigenetic inactivation of miR-203 as a key step in neural crest epithelial-to-mesenchymal transition
Estefanía Sánchez-Vásquez, Marianne Bronner‐Fraser, Pablo H. Strobl‐Mazzulla
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Aug 2018
1 citation
1 citation
1924 days before retraction
Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis
Warangkana Lohcharoenkal, Kunal Das Mahapatra, Lorenzo Pasquali et al. (13 authors)
Journal of Investigative Dermatology
Open Access
Published: Feb 2018
40 citations
40 citations
2106 days before retraction
Glucocorticoids Improve Myogenic Differentiation In Vitro by Suppressing the Synthesis of Versican, a Transitional Matrix Protein Overexpressed in Dystrophic Skeletal Muscles
Natasha L. McRae, Leonard G. Forgan, B. A. McNeill et al. (7 authors)
International Journal of Molecular Sciences
Open Access
Published: Dec 2017
26 citations
26 citations
2175 days before retraction
MiR-135a-5p modulates biological functions of thyroid carcinoma cells via targeting VCAN 3′-UTR
Xue Zhao, Zhigui Sun, Hui Li et al. (6 authors)
Cancer Biomarkers
Published: Aug 2017
37 citations
37 citations
2280 days before retraction
miR-124 inhibits proliferation, migration and invasion of malignant melanoma cells via targeting versican
Ping Yang, Pingyuan Bu, Chengyuan Li
Experimental and Therapeutic Medicine
Open Access
Published: Aug 2017
13 citations
13 citations
2281 days before retraction
MiRNAs in Malignant Melanoma
Marina Mione, Janika K. Liebig, Leonel Muñoz et al. (4 authors)
Springer eBooks
Published: Jan 2017
3 citations
3 citations
2514 days before retraction
MicroRNA-9 suppresses the growth, migration, and invasion of malignant melanoma cells via targeting NRP1
Dan Xu, Xiaofeng Chen, Quanyong He et al. (4 authors)
OncoTargets and Therapy
Open Access
Published: Nov 2016
21 citations
21 citations
2575 days before retraction
RAB22A overexpression promotes the tumor growth of melanoma
Feng Su, Yifei Chen, Shilin Zhu et al. (8 authors)
Oncotarget
Open Access
Published: Sep 2016
23 citations
23 citations
2609 days before retraction
Pivotal MicroRNAs in Melanoma: A Mini-Review
Zhenjun Deng, Hao Jin-gang, Dongyun Lei et al. (6 authors)
Molecular Diagnosis & Therapy
Published: Jun 2016
8 citations
8 citations
2701 days before retraction
MicroRNA-18b inhibits the growth of malignant melanoma via inhibition of HIF-1α-mediated glycolysis
Yao Chen, Ziqing Zhang, Chengqun Luo et al. (5 authors)
Oncology Reports
Open Access
Published: May 2016
28 citations
28 citations
2740 days before retraction
Decreased expression of hyaluronan synthase 1 and 2 associates with poor prognosis in cutaneous melanoma
Mari Poukka, Andrey Bykachev, Hanna Siiskonen et al. (7 authors)
BMC Cancer
Open Access
Published: May 2016
16 citations
16 citations
2744 days before retraction
Inhibition of versican expression by siRNA facilitates tropoelastin synthesis and elastic fiber formation by human SK-LMS-1 leiomyosarcoma smooth muscle cells in vitro and in vivo
Paul Keire, Steven L. Bressler, Eileen R. Mulvihill et al. (6 authors)
Matrix Biology
Open Access
Published: Dec 2015
19 citations
19 citations
2888 days before retraction
miRNAs in melanoma: a defined role in tumor progression and metastasis
Francesco Mannavola, Marco Tucci, Claudia Felici et al. (5 authors)
Expert Review of Clinical Immunology
Published: Oct 2015
42 citations
42 citations
2946 days before retraction
MicroRNA-203 induces apoptosis by upregulating Puma expression in colon and lung cancer cells
Naotake Funamizu, Curtis Lacy, Minori Kamada et al. (5 authors)
International Journal of Oncology
Open Access
Published: Sep 2015
24 citations
24 citations
2981 days before retraction
miR-203 Inhibits Frizzled-2 Expression via CD82/KAI1 Expression in Human Lung Carcinoma Cells
Mariko Mine, Kojiro Yamaguchi, Tsuyoshi Sugiura et al. (9 authors)
PLoS ONE
Open Access
Published: Jul 2015
33 citations
33 citations
3064 days before retraction
Micro<scp>RNA</scp>s in melanocyte and melanoma biology
Marina Mione, Anja-Katrin Boßerhoff
Pigment Cell & Melanoma Research
Open Access
Published: Dec 2014
59 citations
59 citations
3260 days before retraction
A Role for Versican in the Development of Leiomyosarcoma
Paul Keire, Steven L. Bressler, Joan M. Lemire et al. (9 authors)
Journal of Biological Chemistry
Open Access
Published: Oct 2014
33 citations
33 citations
3322 days before retraction
Quick Stats
Total Citations:
28
Years Since Retraction:
2.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025